ClinConnect ClinConnect Logo
Search / Trial NCT07126041

Scalable Public Health Empowerment, Research, and Education Sites (SPHERES)

Launched by EIJKMAN OXFORD CLINICAL RESEARCH UNIT, INDONESIA · Aug 9, 2025

Trial Information

Current as of August 22, 2025

Not yet recruiting

Keywords

Primary Health Care Performance Digital Health Transformation Maternal Health Child Health Immunization Stunting Tuberculosis Hepatitis B Diabetes Mellitus Hypertension Health System Strengthening Indonesia Health Governance Human Resource Management Work Culture

ClinConnect Summary

This clinical trial, called SPHERES, is looking at ways to improve health care in Indonesia, especially for pregnant women, newborn babies, and people with illnesses like tuberculosis, hepatitis B, high blood pressure, and diabetes. The goal is to help local health leaders use information and data more effectively to make better decisions that improve health services for these groups. Instead of testing a new medicine, this study focuses on improving how health care is delivered in local clinics and health offices.

People who live in the areas served by participating health centers and who use these health services may be part of this study, along with health care workers and district health officials who agree to take part. If you or your family members receive care from these facilities, you could be eligible. Participants won’t be undergoing medical treatments but will be involved in sharing information to help health leaders understand what’s working and what can be improved. The study is not yet recruiting participants, but it aims to make health care better for many people in the community by supporting smarter decisions based on real data.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Residing in or participating in the district catchment areas
  • Receiving services from participating health care facilities
  • Health providers and district health officials consent to participate in data collection
  • Exclusion Criteria:
  • Individuals (health workers or patients) who decline to provide informed consent.
  • Individuals who are not directly involved in or accessing services from health care facilities or district health offices.
  • Inability to provide consent due to cognitive impairment or acute illness for health workers or district health officials involved in data collection

About Eijkman Oxford Clinical Research Unit, Indonesia

The Eijkman Oxford Clinical Research Unit (EOCRU) in Indonesia is a leading research institution dedicated to advancing clinical research in infectious diseases and public health. A collaboration between the Eijkman Institute for Molecular Biology and the University of Oxford, EOCRU focuses on conducting high-quality clinical trials that address pressing health challenges in Indonesia and the Southeast Asian region. With a commitment to ethical research practices and community engagement, EOCRU leverages cutting-edge scientific methodologies and a multidisciplinary approach to contribute valuable insights into disease prevention, treatment, and management, ultimately enhancing health outcomes in diverse populations.

Locations

Purbalingga, Central Java, Indonesia

Gerung, West Nusa Tenggara, Indonesia

Patients applied

0 patients applied

Trial Officials

Anuraj H Shankar, D. Sc.

Principal Investigator

Oxford University Clinical Research Unit Indonesia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported